Pasithea Therapeutics Brings New Depression Treatments To London
Pasithea Therapeutics Corp. (KTTA)
Company Research
Source: PR Web
LONDON (PRWEB) November 22, 2021 With on-the-ground operations in both the United States and United Kingdom, Pasithea Therapeutics is working to bring treatments for depression and other mental health disorders to more people. Through a partnership with Zen Healthcare, Pasithea recently opened a clinic in the heart of Knightsbridge.As reported by Benzinga, a study from the Canadian Rapid Treatment Centre of Excellence found that patients who used solely a Ketamine IV for anti-depression experienced higher response and remission rates than those who used both Ketamine and oral supplements. This has led to promising developments and new clinical trials being run on a number of new substances, like ketamine, to test for their use in treating mental health ailments like depression. According to the BBC, ketamine trials have been tested for depression since 2011, but interests have become reinvigorated due to work in other countries. In bringing the ketamine clinic to the UK, Pasithea is
Show less
Read more
Impact Snapshot
Event Time:
KTTA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KTTA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KTTA alerts
High impacting Pasithea Therapeutics Corp. news events
Weekly update
A roundup of the hottest topics
KTTA
News
- Pasithea Therapeutics Announces Opening of Enrollment in the U.S. for its Phase 1 Trial of PAS-004 [Yahoo! Finance]Yahoo! Finance
- Pasithea Therapeutics Announces Opening of Enrollment in the U.S. for its Phase 1 Trial of PAS-004GlobeNewswire
- Global Sleep Apnea Diagnostic Systems Clinical Pipeline Research Report 2023: Analysis by Stages of Development, Key Segments, Region and Countries, Regulatory Path and Key Companies [Yahoo! Finance]Yahoo! Finance
KTTA
Sec Filings
- 4/5/24 - Form 4/A
- 4/5/24 - Form 4/A
- 4/5/24 - Form 4/A
- KTTA's page on the SEC website